Evaluation of Lateral Spread of Transgene Expression following Subretinal AAV-Mediated Gene Delivery in Dogs

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Bruewer, Ashlee R ^a   Mowat, Freya M ^a   Bartoe, Joshua T ^a   Boye, Sanford L ^b   Hauswirth, William W ^b   Petersen Jones, Simon M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; GENE EXPRESSION; GENETIC TRANSDUCTION; INJECTION; MALE; NONHUMAN; OPTIC NERVE; PROMOTER REGION; REPORTER GENE; RETINA DETACHMENT; RETINA FOVEA; SUBRETINAL INJECTION BLEB; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ACTINS; ANIMALS; CAPSID PROTEINS; CHICKENS; DEPENDOVIRUS; DOGS; ELECTRORETINOGRAPHY; GENES, REPORTER; GENETIC THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INJECTIONS, INTRAOCULAR; MALE; MICROSCOPY, FLUORESCENCE; OPTIC NERVE; PROMOTER REGIONS, GENETIC; RETINA; RETINAL DETACHMENT; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS; CANIS FAMILIARIS; MIRIDAE;

EID: 84875690657     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060218     Document Type: Article

References (31)

1. Berson EL, (2008) Retinal degenerations: planning for the future. Adv Exp Med Biol 613: 21-35.
2. Stone EM, (2007) Leber congenital amaurosis- a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture. Am J Ophthalmol 144: 791-811.
3. Beltran WA, (2009) The use of canine models of inherited retinal degeneration to test novel therapeutic approaches. Vet Ophthalmol 12: 192-204.
4. Baehr W, Frederick JM, (2009) Naturally occurring animal models with outer retina phenotypes. Vision Res 49: 2636-2652.
5. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, et al. (2001) Gene therapy restores vision in a canine model of childhood blindness. Nat genet 28: 92-95.
6. Guziewicz KE, Zangerl B, Lindauer SJ, Mullins RF, Sandmeyer LS, et al. (2007) Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for best disease. Invest Ophthalmol Vis Sci 48: 1959-1967.
7. Sidjanin DJ, Lowe JK, McElwee JL, Milne BS, Phippen TM, et al. (2002) Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3. Hum Mol Genet 11: 1823-1833.
8. Kijas JW, Cideciyan AV, Aleman TS, Pianta MJ, Pearce-Kelling SE, et al. (2002) Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa. Proc Natl Acad Sci USA 99: 6328-6333.
9. Beltran WA, Hammond P, Acland GM, Aguirre GD, (2006) A Frameshift Mutation in RPGR Exon ORF15 Causes Photoreceptor Degeneration and Inner Retina Remodeling in a Model of X-Linked Retinitis Pigmentosa. Investigative Ophthalmology and Visual Science 47: 1669-1681.
10. Tuntivanich N, Pittler SJ, Fischer AJ, Omar G, Kiupel M, et al. (2009) Characterization of a canine model of autosomal recessive retinitis pigmentosa due to a PDE6A mutation. Invest Ophthalmol Vis Sci 50: 801-813.
11. Suber ML, Pittler SJ, Quin N, Wright GC, Holcombe N, et al. (1993) Irish setter dogs affected with rod-cone dysplasia contain a nonsense mutation in the rod cGMP phosphodiesterase beta-subunit gene. Proc Natl Acad Sci USA 90: 3968-3972.
12. Komaromy AM, Alexander JJ, Rowlan JS, Garcia MM, Chiodo VA, et al. (2010) Gene therapy rescues cone function in congenital achromatopsia. Hum Mol Genet 19: 2581-2593.
13. Beltran WA, Cideciyan AV, Lewin AS, Iwabe S, Khanna H, et al. (2012) Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa. Proc Natl Acad Sci USA 109: 2132-2137.
14. Mowat FM, Bartoe JT, Bruewer A, Dinculescu A, Boye SL, et al. (2012) Evaluation Of Rod Photoreceptor Function And Preservation Following Retinal Gene Therapy In The PDE6A Mutant Dog. ARVO Meeting Abstracts 53: 1928.
15. Petit L, Lheriteau E, Weber M, Le Meur G, Deschamps JY, et al. (2012) Restoration of Vision in the pde6beta-deficient Dog, a Large Animal Model of Rod-cone Dystrophy. Mol Ther 20: 2019-2030.
16. Auricchio A, Rolling F, (2005) Adeno-associated viral vectors for retinal gene transfer and treatment of retinal diseases. Curr Gene Ther 5: 339-348.
17. Buch PK, Bainbridge JW, Ali RR, (2008) AAV-mediated gene therapy for retinal disorders: from mouse to man. Gene Ther 15: 849-857.
18. McCarty DM, Fu H, Monahan PE, Toulson CE, Naik P, et al. (2003) Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther 10: 2112-2118.
19. McCarty DM, (2008) Self-complementary AAV vectors; advances and applications. Mol Ther 16: 1648-1656.
20. Natkunarajah M, Trittibach P, McIntosh J, Duran Y, Barker SE, et al. (2008) Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8. Gene Ther 15: 463-467.
21. Petersen-Jones SM, Bartoe JT, Fischer AJ, Scott M, Boye SL, et al. (2009) AAV retinal transduction in a large animal model species: comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vector. Mol Vis 15: 1835-1842.
22. Zhong L, Li B, Mah CS, Govindasamy L, Agbandje-McKenna M, et al. (2008) Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc Natl Acad Sci USA 105: 7827-7832.
23. Petrs-Silva H, Dinculescu A, Li Q, Min SH, Chiodo V, et al. (2009) High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther 17: 463-471.
24. Petrs-Silva H, Dinculescu A, Li Q, Deng WT, Pang JJ, et al. (2011) Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. Mol Ther 19: 293-301.
25. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, et al. (2008) Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358: 2231-2239.
26. Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, et al. (2012) Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 130: 9-24.
27. Stieger K, Colle MA, Dubreil L, Mendes-Madeira A, Weber M, et al. (2008) Subretinal delivery of recombinant AAV serotype 8 vector in dogs results in gene transfer to neurons in the brain. Mol Ther 16: 916-923.
28. Hauswirth WW, Lewin AS, Zolotukhin S, Muzyczka N, (2000) Production and purification of recombinant adeno-associated virus. Methods Enzymol 316: 743-761.
29. Schneider CA, Rasband WS, Eliceiri KW, (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
30. Bartoe JT, Mowat F, Dinculescu A, Boye S, Hauswirth W, et al. (2011) AAV Vectors With Engineered Capsid Mutations Efficiently Transduce Outer Retina With Intravitreal Delivery And Result In Rapid Gene Expression With Subretinal Delivery In Dogs. ARVO Meeting Abstracts 52: 1420.
31. Verdugo ME, Ailing J, Lazar ES, del Cerro M, Ray J, et al. (2001) Posterior segment approach for subretinal transplantation or injection in the canine model. Cell Transplant 10: 317-327.